Corporate Raider Carl Icahn, Illumina Discussed Settlement Before Proxy Fight
Icahn, a legendary "corporate raider" who now owns 1.4% of Illumina, has been pushing for the genetic sequencing pioneer to unwind its buyout of cancer detection test maker Grail and is seeking three board seats.